Cargando…
Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia
In about 95% of cases, congenital adrenal hyperplasia (CAH) is caused by mutations in CYP21A2 gene encoding steroid 21-hydroxylase (21OH). Recently, we have reported four novel CYP21A2 variants in the Norwegian population of patients with CAH, of which p.L388R and p.E140K were associated with salt w...
Autores principales: | Brønstad, Ingeborg, Breivik, Lars, Methlie, Paal, Wolff, Anette S B, Bratland, Eirik, Nermoen, Ingrid, Løvås, Kristian, Husebye, Eystein S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987286/ https://www.ncbi.nlm.nih.gov/pubmed/24671123 http://dx.doi.org/10.1530/EC-14-0032 |
Ejemplares similares
-
Assay of steroids by liquid chromatography–tandem mass spectrometry in monitoring 21-hydroxylase deficiency
por: Dahl, Sandra R, et al.
Publicado: (2018) -
Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019) -
Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
por: Nermoen, Ingrid, et al.
Publicado: (2009) -
Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas
por: Ueland, Grethe Å, et al.
Publicado: (2020) -
Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease
por: Brønstad, Ingeborg, et al.
Publicado: (2011)